BACK
|Enrolling

Influenza Vaccine

This is a Phase 3, randomized, observer-blinded study to evaluate the efficacy, safety, tolerability, and immunogenicity of a single dose of a quadrivalent influenza modRNA vaccine compared to licensed inactivated influenza vaccine in healthy adults 18 years of age and older.

More Information

Capital Area Research LLC © Copyright 2023 All rights reserved.
875 Popular Church Rd. Suite 330 Camp Hill, PA - 717.963.8389